-- Robert Preidt
WEDNESDAY, May 9 (HealthDay News) -- One in six cancers
worldwide is caused by preventable or treatable infections, a new
Infections cause about 2 million cancer cases a year, and 80
percent of those cases occur in less developed areas of the world,
according to the study, which was published online May 8 in
The Lancet Oncology. Of the 7.5 million cancer deaths worldwide in 2008, about 1.5 million were due to potentially preventable or treatable infections.
"Infections with certain viruses, bacteria and parasites are one of the biggest and most preventable causes of cancer worldwide," lead authors Catherine de Martel and Martyn Plummer, from the International Agency for Research on Cancer in Lyon, France, said in a journal news release. "Application of existing public-health methods for infection prevention -- such as vaccination, safer injection practice or antimicrobial treatments -- could have a substantial effect on future burden of cancer worldwide."
The researchers examined data on 27 cancers in 184 countries and
calculated that about 16 percent of all cancers in 2008 were
infection-related. The rate of infection-related cancers was 23
percent in developing countries and 7 percent in developed
Rates of infection-related cancers ranged from 3 percent in
Australia and New Zealand to 33 percent in sub-Saharan Africa.
"Many infection-related cancers are preventable, particularly those associated with human papillomavirus (HPV), Helicobacter pylori, and hepatitis B and hepatitis C viruses," the researchers said.
In 2008, these four main infections together caused 1.9 million
cancers, mostly of the stomach, liver and cervix. Cervical cancer
accounted for about half of infection-related cancers in women, and
liver and gastric cancers accounted for more than 80 percent of
infection-related cancers in men.
The study findings "show the potential for preventive and
therapeutic programs in less developed countries to significantly
reduce the global burden of cancer and the vast disparities across
regions and countries," Goodarz Danaei, of the Harvard School of
Public Health in Boston, wrote in an accompanying editorial.
"Since effective and relatively low-cost vaccines for HPV and [hepatitis B] are available, increasing coverage should be a priority for health systems in high-burden countries," Danaei added.
The U.S. National Cancer Institute offers an overview of
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.